(DOWNLOAD) "Xechem, Inc. v. Bristol-Myers Squibb Company" by In the United States Court of Appeals for the Seventh Circuit # eBook PDF Kindle ePub Free

eBook details

Title: Xechem, Inc. v. Bristol-Myers Squibb Company
Author : In the United States Court of Appeals for the Seventh Circuit
Release Date : January 23, 2004
Genre: Law,Books,Professional & Technical,
Pages : * pages
Size : 68 KB

Description

The Hatch-Waxman amendments to the Food and Drug Act entitle pharmaceutical companies that first bring a drug to market to a five-year period of exclusivity, even if the drug is unpatented. 21 U.S.C. Â§355. Bristol-Myers Squibb was first to market with paclitaxel, a compound derived from the bark of the yew tree and useful in combating some cancers. Bristol-Myers calls its formulation Taxol, which has been a commercial success. The exclusivity period was due to expire in July 1997, and many other drug producers geared up to sell generic paclitaxel once the market opened.